Barinthus Biotherapeutics Plc ADR (BRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 75,674 | 87,784 | 100,579 | 112,400 | 106,102 |
| Receivables | 4,633 | 4,536 | 2,997 | 7,139 | 5,403 |
| Other current assets | 138 | 413 | 0 | 0 | 14,969 |
| TOTAL | $86,781 | $100,414 | $109,882 | $125,742 | $134,654 |
| Non-Current Assets | |||||
| PPE Net | 4,519 | 4,514 | 6,201 | 7,373 | 10,719 |
| Intangibles | 14,909 | 20,366 | 21,156 | 21,947 | 34,946 |
| Other Non-Current Assets | 2,992 | 4,267 | 4,757 | 5,265 | 8,370 |
| TOTAL | $22,420 | $29,147 | $32,114 | $34,585 | $54,035 |
| Total Assets | $109,201 | $129,561 | $141,996 | $160,327 | $188,689 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 698 | 1,800 | 1,357 | 2,474 | 3,076 |
| Accrued Expenses | 6,681 | 7,364 | 7,198 | 9,525 | 7,966 |
| TOTAL | $10,798 | $12,725 | $11,976 | $15,657 | $15,072 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,402 | 1,525 | 1,461 | 1,738 | 2,044 |
| Other Non-Current Liabilities | 13,527 | 13,966 | 14,021 | 14,148 | 13,714 |
| TOTAL | $13,842 | $14,355 | $14,427 | $14,535 | $14,156 |
| Total Liabilities | $24,640 | $27,080 | $26,403 | $30,192 | $29,228 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 40,830 | 40,718 | 40,339 | 40,339 | 40,228 |
| Common Shares | 87 | 87 | 87 | 87 | 87 |
| Retained earnings | -293,002 | -278,436 | -257,312 | -237,664 | -217,124 |
| Other shareholders' equity | -15,772 | -12,833 | -21,126 | -25,762 | -15,384 |
| TOTAL | $84,561 | $102,481 | $115,593 | $130,135 | $159,461 |
| Total Liabilities And Equity | $109,201 | $129,561 | $141,996 | $160,327 | $188,689 |